Medical Thermoplastic Elastomers (TPE) Market latest Statistics on Market Size, Growth, Production, Sales Volume, Sales Price, Market Share and Import vs Export 

Medical Thermoplastic Elastomers (TPE) Market Summary Highlights

The global Medical Thermoplastic Elastomers (TPE) Market is estimated at nearly USD 3.5 billion in 2026, supported by expanding demand for flexible, biocompatible, and sterilization-resistant materials across catheters, medical tubing, respiratory devices, wearable monitoring systems, and disposable healthcare products. Medical-grade elastomers are increasingly replacing conventional PVC and latex materials due to stricter compliance requirements related to patient safety, chemical migration, and sustainability. Thermoplastic polyurethane (TPU) continues to account for the largest material share, while styrenic block copolymers and thermoplastic vulcanizates are gaining wider acceptance in soft-touch and single-use applications.

The industry is also being shaped by rising investments in healthcare manufacturing capacity. In September 2024, Avient expanded production capacity for medical TPU materials used in catheter and minimally invasive applications. In August 2024, Trelleborg strengthened its engineered polymer portfolio through the acquisition of Magee Plastics, targeting healthcare and specialty thermoplastic applications. Similar expansion activity across Asia-Pacific and North America reflects increasing competition among material suppliers to secure long-term contracts with medical device manufacturers.

Statistical Highlights

• Global Medical Thermoplastic Elastomers (TPE) Market projected at approximately USD 3.5 billion in 2026
• Market forecast expected to surpass USD 5.3 billion by 2035
• Estimated CAGR during 2026–2035 projected near 4.7%
• Thermoplastic polyurethane grades account for more than 50% of global medical elastomer demand
• Medical tubing and catheter applications contribute close to 30% of total consumption
• North America holds nearly 35% share of global demand due to strong medical device manufacturing activity
• Asia-Pacific expected to record the fastest growth with projected CAGR above 6% through 2035
• Wearable healthcare devices using flexible medical polymers projected to grow over 9% annually through 2030
• Single-use medical device production in Asia expected to expand above 7% annually through 2029
• Demand for phthalate-free medical elastomers expected to exceed 70% penetration in developed healthcare markets by 2030
• Injection molding remains the dominant processing technology for medical TPE applications
• Specialty transparent and antimicrobial elastomer grades are witnessing above-average adoption in advanced healthcare systems

Rising Demand for Minimally Invasive Medical Devices

One of the strongest growth contributors for the Medical Thermoplastic Elastomers (TPE) Market is the rapid increase in minimally invasive surgical and diagnostic procedures. Catheters, guidewires, introducers, infusion systems, and endoscopic devices require materials that combine flexibility, chemical resistance, kink stability, and sterilization durability. Medical-grade thermoplastic elastomers are increasingly preferred because they can meet these performance requirements while supporting complex extrusion and molding processes.

Healthcare systems are performing a larger number of cardiovascular, urology, gastroenterology, and neurovascular procedures using minimally invasive techniques. This shift directly increases demand for flexible tubing systems and soft polymer components. Thermoplastic polyurethane materials are witnessing particularly strong adoption in catheter manufacturing because of their abrasion resistance and biocompatibility characteristics.

Medical tubing remains one of the highest-volume applications within the Medical Thermoplastic Elastomers (TPE) Market. Demand is expanding across IV administration systems, respiratory tubing, enteral feeding systems, dialysis equipment, and fluid management devices. Manufacturers are increasingly requesting transparent elastomer grades capable of withstanding gamma and ethylene oxide sterilization without discoloration or loss of flexibility.

The transition toward outpatient care settings is also increasing procurement of disposable medical products. Ambulatory surgery centers and home healthcare providers require lightweight and cost-efficient polymer-based systems that reduce infection risks and simplify waste management. This trend continues supporting higher consumption of medical elastomers across disposable applications.

Regulatory Shift Away from PVC and Latex Materials

Healthcare regulators and procurement agencies are steadily reducing dependence on PVC and latex materials in patient-contact applications. Concerns regarding phthalate migration, allergic reactions, and long-term chemical exposure are encouraging hospitals and device manufacturers to adopt alternative elastomer systems.

Medical Thermoplastic Elastomers (TPE) are increasingly replacing conventional rubber materials in blood-contact applications, neonatal care products, infusion systems, respiratory masks, and wearable healthcare devices. These materials offer improved softness, lower odor, enhanced recyclability, and better compatibility with multi-material device designs.

European healthcare systems continue leading the shift toward phthalate-free medical materials. Several hospital procurement programs across Germany, Scandinavia, and the Netherlands now prioritize PVC-free disposable systems. Similar procurement changes are becoming visible across North America and advanced Asia-Pacific healthcare markets.

Material suppliers are responding by introducing ultra-soft elastomer grades with improved tactile performance and lower extractable content. Thermoplastic vulcanizates and styrenic block copolymers are gaining attention in disposable medical products because they allow faster processing cycles and lower manufacturing costs compared to traditional thermoset rubber.

In 2025, multiple healthcare polymer manufacturers increased investment in bio-based elastomer technologies and recyclable medical compounds to align with sustainability targets set by healthcare institutions and medical OEMs. This sustainability push is gradually influencing purchasing decisions among large hospital networks and diagnostic equipment manufacturers.

Expansion of Wearable Healthcare Technologies

Wearable healthcare systems are emerging as a major consumption segment for medical elastomers. Flexible sensors, remote monitoring devices, smart patches, insulin delivery systems, and portable diagnostic equipment require materials capable of maintaining skin compatibility during prolonged use.

The Medical Thermoplastic Elastomers (TPE) Market is benefiting from the expansion of connected healthcare infrastructure and chronic disease monitoring programs. Aging populations and rising diabetes prevalence are increasing adoption of wearable monitoring systems that depend on lightweight and flexible polymer structures.

Thermoplastic polyurethane grades are increasingly used in wearable medical electronics because they combine elasticity with abrasion resistance and transparency. Advanced formulations are also being engineered with antimicrobial additives and radiopaque properties for specialized clinical applications.

Asia-Pacific is witnessing rapid expansion in wearable healthcare manufacturing capacity. China, South Korea, Japan, and Singapore continue investing heavily in digital healthcare ecosystems and remote patient monitoring technologies. This regional expansion is creating strong downstream demand for medical elastomers used in micro-extrusion, injection molding, and overmolding applications.

Device miniaturization is another important factor supporting material innovation. Smaller and lighter devices require elastomers capable of maintaining structural integrity under repeated flexing conditions. Manufacturers are therefore increasing investment in specialty compounds with improved fatigue resistance and thermal stability.

Growing Importance of Single-Use Medical Products

Single-use medical products continue gaining preference across hospitals and diagnostic laboratories due to infection control requirements and operational efficiency advantages. Disposable syringes, tubing assemblies, connectors, fluid bags, respiratory masks, and surgical components increasingly rely on medical elastomers for flexibility and patient comfort.

Demand accelerated further after healthcare systems expanded stockpiles of disposable respiratory and diagnostic equipment during recent public health preparedness initiatives. Medical device manufacturers are now prioritizing scalable polymer solutions that allow faster production throughput while maintaining compliance with international biocompatibility standards.

Injection molding remains the dominant manufacturing process for disposable medical elastomer components. Medical TPE compounds provide shorter cycle times and easier color customization compared to silicone and vulcanized rubber alternatives. This processing advantage is helping thermoplastic elastomers secure larger market share across high-volume healthcare applications.

The shift toward home healthcare and self-administered treatment systems is also increasing demand for ergonomic and soft-touch medical devices. Patients increasingly prefer lightweight wearable and handheld systems that improve comfort during prolonged use, further supporting elastomer adoption.

Asia-Pacific Emerging as a Manufacturing Powerhouse

Asia-Pacific is expected to remain the fastest-growing regional market for medical elastomers through the next decade. China, India, Malaysia, Thailand, and Vietnam continue strengthening their positions as manufacturing hubs for disposable medical products and healthcare consumables.

China remains a leading producer of medical tubing systems, connectors, respiratory components, and diagnostic disposables. Government-backed investments in domestic healthcare manufacturing are supporting long-term demand for specialty polymer materials.

India is also expanding local production of infusion systems, respiratory equipment, and wearable healthcare devices under domestic manufacturing incentive programs. Rising healthcare infrastructure spending and improving export capabilities are encouraging global material suppliers to expand distribution networks across the region.

Meanwhile, Japanese and South Korean manufacturers continue focusing on high-value specialty elastomers designed for precision medical devices and robotic-assisted surgical systems. These markets are prioritizing advanced transparent TPU grades, antimicrobial compounds, and ultra-soft elastomers for next-generation healthcare technologies.

Raw Material Cost Pressure and Margin Challenges

Despite strong long-term demand indicators, profitability conditions across the Medical Thermoplastic Elastomers (TPE) Market remain uneven because of fluctuations in petrochemical feedstock pricing. Polyurethane intermediates, styrene derivatives, and specialty additives continue experiencing periodic supply disruptions and energy-related cost volatility.

Medical-grade elastomer manufacturing requires strict purity standards and extensive compliance testing, limiting supplier flexibility during raw material shortages. Smaller compounders and regional manufacturers remain particularly vulnerable to margin pressure during periods of elevated feedstock costs.

To manage pricing risks, manufacturers are increasingly adopting long-term procurement agreements, vertical integration strategies, and process optimization initiatives. Several companies are also accelerating development of recyclable and bio-based elastomer systems to reduce dependence on conventional petrochemical inputs while meeting healthcare sustainability objectives.

Regional Demand Dynamics in the Medical Thermoplastic Elastomers (TPE) Market

North America continues to account for the largest share of the Medical Thermoplastic Elastomers (TPE) Market due to strong medical device manufacturing capacity, high procedural volumes, and early adoption of advanced polymer technologies. The United States alone represents a substantial portion of global demand for medical-grade TPU and styrenic elastomers used in catheters, drug-delivery systems, wearable monitoring devices, and respiratory applications.

The region’s demand structure is heavily influenced by cardiovascular disease prevalence, aging demographics, and rising outpatient procedures. The American Hospital Association estimated U.S. hospital expenditure growth above 5% entering 2026, supporting procurement of disposable medical products and minimally invasive surgical systems. This is directly increasing consumption of flexible elastomeric compounds across fluid-management and patient-contact applications.

Demand growth is also linked to wearable healthcare expansion. North America remains one of the largest markets for continuous glucose monitoring systems and connected patient monitoring technologies. These products require soft-touch and skin-compatible elastomers capable of repeated flexing and long-duration use. Medical-grade TPU demand in wearable electronics applications is projected to maintain annual growth above 8% through the next several years.

Europe maintains a strong position in high-value medical elastomer consumption, particularly in Germany, France, Switzerland, Ireland, and the Nordic countries. Regulatory pressure regarding phthalate-containing PVC materials continues to accelerate replacement demand for thermoplastic elastomers. Hospitals and healthcare procurement agencies increasingly specify PVC-free tubing systems, respiratory masks, and infusion products.

Germany remains one of the most important European manufacturing hubs for precision medical equipment and minimally invasive surgical devices. Demand for transparent and sterilization-resistant elastomers is especially strong in diagnostic systems and advanced catheter applications. European healthcare systems are also placing greater emphasis on sustainability compliance, encouraging use of recyclable elastomer compounds and bio-based TPU formulations.

Asia-Pacific is expected to record the fastest expansion in the Medical Thermoplastic Elastomers (TPE) Market through 2035. China remains the dominant regional manufacturing center for disposable medical consumables, tubing assemblies, respiratory products, and fluid transfer systems. Domestic healthcare investment and export-oriented medical manufacturing continue driving material demand upward.

China’s National Health Commission continues supporting expansion of local medical device manufacturing capacity, particularly in high-volume consumables and diagnostic systems. This has strengthened procurement activity for medical elastomers used in injection molding and extrusion operations. Demand growth is further supported by rapid expansion in private healthcare infrastructure and aging population trends.

India is emerging as a major downstream consumer of medical elastomers due to increasing domestic production of infusion systems, respiratory equipment, and diagnostic disposables. Government-backed manufacturing incentives under healthcare and pharmaceutical production programs are encouraging expansion of local medical polymer processing operations. Demand for medical tubing and flexible connectors is increasing steadily as hospitals continue modernizing critical care infrastructure.

Japan and South Korea continue focusing on high-performance specialty elastomers used in robotic-assisted surgery systems, advanced wearable devices, and precision diagnostic equipment. These countries emphasize premium-grade compounds with superior transparency, chemical resistance, and dimensional stability.

Latin America and the Middle East remain comparatively smaller markets but continue showing steady demand growth due to improving healthcare access and rising imports of disposable medical products. Brazil, Mexico, Saudi Arabia, and the UAE are investing heavily in hospital modernization and domestic healthcare manufacturing capabilities, indirectly supporting regional elastomer demand.

Medical Thermoplastic Elastomers (TPE) Production Trends

Global Medical Thermoplastic Elastomers (TPE) production continues shifting toward Asia-Pacific due to lower manufacturing costs, expanding medical device exports, and rising cleanroom processing investments. China accounts for the largest share of Medical Thermoplastic Elastomers (TPE) production capacity in volume terms, supported by integrated petrochemical infrastructure and extensive downstream extrusion and injection molding operations.

Medical Thermoplastic Elastomers (TPE) production in Asia is projected to increase by more than 6% annually through 2030 as manufacturers expand output for tubing, catheters, wearable healthcare components, and disposable respiratory products. Several multinational polymer producers are increasing regional compounding operations to secure supply agreements with medical OEMs located in China, Malaysia, Vietnam, and India.

North America remains a critical center for high-value Medical Thermoplastic Elastomers (TPE) production, especially for advanced TPU grades used in minimally invasive devices and implant-adjacent applications. U.S.-based manufacturers continue investing in medical-grade compounding lines with enhanced traceability and low-extractable formulations.

European production trends are increasingly influenced by sustainability mandates and circular polymer initiatives. Germany and Switzerland remain important hubs for specialty medical elastomer compounds designed for high-precision healthcare applications. Production investments are increasingly focused on recyclable thermoplastic formulations and bio-based feedstock integration.

Segmentation Highlights

By Material Type

• Thermoplastic polyurethane (TPU) remains the leading segment with more than half of global medical elastomer consumption
• Styrenic block copolymers gaining strong demand in disposable healthcare products
• Thermoplastic vulcanizates witnessing higher usage in soft-touch medical equipment
• Copolyester elastomers expanding in transparent tubing applications
• Polyolefin-based elastomers increasingly used in lightweight medical packaging systems

By Application

• Medical tubing and catheters account for the largest application share
• Wearable healthcare devices showing the fastest growth trajectory
• Respiratory equipment demand remains elevated due to long-term healthcare preparedness investments
• Drug-delivery systems continue increasing elastomer usage in flexible components
• Surgical instruments and grips generating stable replacement demand

By Processing Technology

• Injection molding dominates production volumes due to high throughput efficiency
• Extrusion remains critical for tubing and catheter manufacturing
• Blow molding applications increasing in fluid management systems
• Overmolding technology gaining adoption in wearable and ergonomic medical devices

By End User

• Hospitals remain the largest procurement segment
• Ambulatory surgery centers increasing demand for disposable devices
• Home healthcare applications showing strong elastomer consumption growth
• Diagnostic laboratories expanding purchases of flexible fluid-transfer products

Medical Thermoplastic Elastomers (TPE) Price Trend Analysis

The Medical Thermoplastic Elastomers (TPE) Price environment remains strongly influenced by fluctuations in petrochemical feedstocks, energy costs, and medical-grade compliance requirements. Prices for TPU and styrenic elastomers increased moderately through portions of 2024 and 2025 due to elevated polyurethane intermediate costs and supply-chain disruptions affecting specialty additives.

Medical-grade materials command significantly higher premiums than industrial elastomers because of stringent biocompatibility testing, regulatory certifications, and traceability requirements. High-purity TPU compounds used in catheter and implant-adjacent applications often trade at price levels 25% to 40% higher than standard industrial TPU grades.

The Medical Thermoplastic Elastomers (TPE) Price Trend in North America remained relatively firm entering 2026 due to strong healthcare manufacturing demand and higher labor costs associated with medical compounding operations. Suppliers focused on premium transparent and sterilization-resistant grades maintained pricing leverage because of limited availability and specialized processing requirements.

In Europe, the Medical Thermoplastic Elastomers (TPE) Price Trend has been shaped by energy market volatility and sustainability-related production costs. Bio-based and recyclable elastomer compounds continue carrying premium pricing due to limited commercial-scale supply and higher raw material conversion expenses. However, large hospital procurement programs increasingly accept these premiums to align with sustainability objectives.

Asia-Pacific continues offering the most competitive pricing environment due to lower production costs and larger-scale manufacturing infrastructure. China remains the primary supplier of cost-efficient medical elastomer compounds for disposable healthcare applications. Nevertheless, rising environmental compliance costs and stricter quality standards are gradually narrowing the price gap between Asian and Western suppliers.

Medical Thermoplastic Elastomers (TPE) Price movements also vary considerably by application category. High-performance TPU grades designed for minimally invasive devices, wearable electronics, and precision tubing continue experiencing stronger price resilience than commodity disposable-grade elastomers. Suppliers capable of offering customized formulations and low-extractable compounds are maintaining healthier margins despite feedstock volatility.

Long-term pricing patterns indicate moderate upward pressure as healthcare manufacturers demand more specialized elastomer formulations with antimicrobial properties, enhanced transparency, and sustainability compliance. Material suppliers are increasingly investing in premium product differentiation rather than competing solely on volume-based pricing.

Leading Manufacturers in the Medical Thermoplastic Elastomers (TPE) Market

The competitive structure of the Medical Thermoplastic Elastomers (TPE) Market remains concentrated among a group of multinational specialty polymer manufacturers with established medical-grade compounding capabilities, regulatory certifications, and long-term supply relationships with healthcare OEMs. Market competition is driven less by commodity pricing and more by product consistency, sterilization performance, biocompatibility compliance, and customized formulation expertise.

Large manufacturers continue strengthening their positions through investments in healthcare-focused production lines, sustainable elastomer technologies, and advanced thermoplastic polyurethane formulations designed for minimally invasive devices and wearable healthcare applications. Supplier qualification cycles in medical applications remain lengthy, creating relatively high entry barriers for smaller compounders.

The Medical Thermoplastic Elastomers (TPE) Market is dominated by companies including Avient Corporation, Teknor Apex, Lubrizol, KRAIBURG TPE, HEXPOL, BASF, Celanese, Dow, Covestro, and RTP Company. These manufacturers collectively account for a substantial share of global medical elastomer production capacity.

Avient Expanding Healthcare Elastomer Presence

Avient Corporation continues strengthening its position through its GLS thermoplastic elastomer portfolio and healthcare-focused material platforms. The company supplies Versaflex, Dynaflex, OnFlex, and Versollan product families for medical tubing, wearable healthcare systems, respiratory devices, and soft-touch diagnostic equipment.

Its medical elastomer portfolio is increasingly used in overmolded healthcare components and minimally invasive devices requiring flexibility and sterilization resistance. Demand remains particularly strong for transparent TPU compounds used in catheter and fluid-management applications.

The company has focused heavily on phthalate-free and latex-free formulations as healthcare providers accelerate replacement of traditional PVC-based systems. Investments in antimicrobial and sustainable elastomer technologies are also supporting Avient’s competitive position in premium healthcare applications.

In September 2024, Avient expanded medical TPU production capacity to support rising demand from catheter and minimally invasive device manufacturers. The expansion reflected increasing procurement activity from North American and Asian medical OEMs.

Teknor Apex Strengthening Medical-Grade TPE Portfolio

Teknor Apex remains one of the most important suppliers in the Medical Thermoplastic Elastomers (TPE) Market through its Medalist medical-grade elastomer series. These compounds are widely used in tubing systems, syringe components, respiratory masks, seals, connectors, and disposable healthcare products.

The company maintains strong positioning in styrenic block copolymer compounds designed for healthcare extrusion and injection molding applications. Medalist elastomers are increasingly replacing PVC compounds in applications requiring softness, flexibility, and low extractable content.

Teknor Apex has also increased focus on sustainable healthcare materials, including recyclable elastomer systems and bio-based compound development. Medical device manufacturers are increasingly requesting materials aligned with environmental compliance goals while maintaining strict biocompatibility standards.

In late 2024, the company introduced new medical-grade elastomer formulations for biopharmaceutical tubing systems with improved clarity, pump durability, and chemical resistance. These products targeted pharmaceutical processing and fluid-transfer applications where contamination control remains critical.

Lubrizol Leading in Medical TPU Applications

Lubrizol continues holding a strong position in premium medical thermoplastic polyurethane applications through its Estane and Carbothane product lines. The company remains particularly influential in catheter systems, minimally invasive devices, and wearable healthcare technologies.

Medical-grade TPU demand continues increasing as device manufacturers require materials capable of maintaining flexibility, kink resistance, and sterilization durability under demanding operating conditions. Lubrizol’s materials are widely used in cardiovascular devices, specialty tubing systems, and patient-monitoring technologies.

The company’s competitive strength is closely linked to high-performance extrusion-grade TPU compounds designed for precision medical manufacturing. Demand for transparent and biostable TPU materials remains especially strong in advanced interventional healthcare devices.

In January 2026, Lubrizol showcased advanced medical TPU technologies focused on wearable healthcare systems, flexible devices, and next-generation minimally invasive applications during a major medical technology exhibition in the United States.

KRAIBURG TPE Expanding Global Healthcare Reach

KRAIBURG TPE continues expanding its healthcare elastomer business across Europe, Asia-Pacific, and North America. The company specializes in soft-touch and sterilization-resistant compounds used in patient-contact devices, wearable systems, tubing, seals, and diagnostic products.

Its healthcare compounds are increasingly selected for ergonomic medical equipment requiring comfort, durability, and long-term dimensional stability. The company also benefits from growing European demand for recyclable and PVC-free medical materials.

KRAIBURG’s thermoplastic elastomer solutions are widely utilized in applications requiring repeated sterilization and stable mechanical performance. Its expansion strategy remains focused on specialty healthcare compounds rather than commodity-grade elastomer volumes.

HEXPOL Increasing Focus on Sustainable Medical Elastomers

HEXPOL remains an important participant in the Medical Thermoplastic Elastomers (TPE) Market through its healthcare-focused thermoplastic compounding operations. The company has expanded investment in recyclable elastomer technologies and sustainable medical compounds designed for sensitive healthcare applications.

Its product portfolio supports applications including medical seals, tubing, wearable devices, and fluid-management systems. HEXPOL’s expertise in customized compounding allows it to serve OEMs requiring specialized hardness levels, sterilization compatibility, and regulatory compliance.

The company continues strengthening its thermoplastic elastomer business through integration and expansion strategies focused on healthcare and sustainability-oriented applications. Recyclable thermoplastic elastomers and circular material platforms are becoming increasingly important parts of its long-term growth strategy.

Medical Thermoplastic Elastomers (TPE) Market Share by Manufacturers

The Medical Thermoplastic Elastomers (TPE) Market remains moderately consolidated, with the leading manufacturers accounting for a major portion of global revenue and production capacity. Large suppliers maintain strong positions because medical device companies prioritize consistent quality, traceability, and long-term regulatory support.

Key market share trends include:

• Avient, Teknor Apex, Lubrizol, HEXPOL, and KRAIBURG TPE collectively represent a dominant portion of medical-grade elastomer supply
• TPU-focused suppliers maintain stronger pricing power in high-performance catheter and minimally invasive device applications
• Asian compounders continue increasing market presence in disposable healthcare products and commodity extrusion-grade materials
• European manufacturers remain highly competitive in recyclable and specialty medical elastomer technologies
• North American suppliers continue leading in advanced wearable healthcare and precision medical applications

Competition is increasingly shifting toward customized formulations with enhanced transparency, antimicrobial performance, low extractables, and sustainability compliance rather than purely volume-based pricing.

Product Lines Influencing Competitive Positioning

Several specialized product families continue shaping competitive dynamics within the Medical Thermoplastic Elastomers (TPE) Market.

Major product lines include:

• Medalist medical elastomers from Teknor Apex for tubing and fluid-management systems
• Versaflex and Dynaflex series from Avient for wearable and soft-touch healthcare devices
• Estane and Carbothane TPU grades from Lubrizol for minimally invasive devices and specialty tubing
• Healthcare-focused TPE compounds from KRAIBURG TPE for patient-contact applications
• Medical TPV and specialty elastomer systems from HEXPOL for healthcare and diagnostic products

Manufacturers are increasingly differentiating through sterilization stability, softness retention, process efficiency, and compatibility with multi-material device assembly processes.

Recent News and Industry Developments

• September 2024: Avient expanded medical TPU production capacity to address rising demand from catheter and minimally invasive device manufacturers
• November 2024: Teknor Apex introduced advanced medical elastomer formulations for biopharmaceutical tubing applications with improved clarity and durability
• April 2025: Teknor Apex expanded sustainable elastomer initiatives through recycled-content certification for selected thermoplastic elastomer products
• August 2025: Several healthcare polymer manufacturers accelerated investments in bio-based and recyclable elastomer technologies to align with sustainability targets across hospital procurement systems
• January 2026: Lubrizol presented next-generation medical TPU technologies for wearable healthcare systems and flexible medical devices
• April 2026: HEXPOL strengthened integration of its thermoplastic elastomer operations with increased emphasis on healthcare and sustainable material platforms